3.985
price up icon5.54%   0.195
 
loading
前日終値:
$3.79
開ける:
$3.8
24時間の取引高:
690.82K
Relative Volume:
0.86
時価総額:
$168.90M
収益:
$3.64M
当期純損益:
$-87.37M
株価収益率:
-0.9119
EPS:
-4.37
ネットキャッシュフロー:
$-86.46M
1週間 パフォーマンス:
-3.15%
1か月 パフォーマンス:
+12.04%
6か月 パフォーマンス:
-66.83%
1年 パフォーマンス:
-36.31%
1日の値動き範囲:
Value
$3.72
$4.15
1週間の範囲:
Value
$3.71
$4.285
52週間の値動き範囲:
Value
$2.10
$14.22

Verastem Inc Stock (VSTM) Company Profile

Name
名前
Verastem Inc
Name
セクター
Healthcare (1195)
Name
電話
(781) 292-4200
Name
住所
117 KENDRICK STREET, NEEDHAM, MA
Name
職員
73
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
VSTM's Discussions on Twitter

VSTM を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
VSTM 4.00 168.90M 3.64M -87.37M -86.46M -4.37
VRTX 450.43 115.43B 10.63B -479.80M -1.35B 13.33
REGN 749.43 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 589.59 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 246.65 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 106.86 24.89B 3.30B -501.07M 1.03B 11.54

Verastem Inc Stock (VSTM) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2022-09-07 再開されました Alliance Global Partners Buy
2022-04-29 再開されました Cantor Fitzgerald Overweight
2022-04-14 開始されました RBC Capital Mkts Outperform
2022-03-09 開始されました Truist Buy
2021-07-01 開始されました Alliance Global Partners Buy
2021-05-24 アップグレード BTIG Research Neutral → Buy
2019-06-20 ダウングレード BTIG Research Buy → Neutral
2019-05-10 ダウングレード Raymond James Outperform → Mkt Perform
2018-07-13 開始されました BTIG Research Buy
2018-05-02 開始されました Seaport Global Securities Buy
2018-03-08 開始されました B. Riley FBR, Inc. Buy
2017-09-07 繰り返されました H.C. Wainwright Buy
2017-04-13 開始されました Oppenheimer Outperform
2017-03-24 繰り返されました H.C. Wainwright Buy
2015-09-29 ダウングレード Cantor Fitzgerald Buy → Hold
2015-09-29 ダウングレード JMP Securities Mkt Outperform → Mkt Perform
2015-09-29 ダウングレード Jefferies Buy → Hold
2015-09-29 ダウングレード Raymond James Strong Buy → Outperform
2015-09-28 ダウングレード Mizuho Buy → Neutral
2015-09-28 ダウングレード ROTH Capital Buy → Neutral
2015-09-09 開始されました Raymond James Strong Buy
2015-05-12 繰り返されました UBS Buy
2015-04-08 開始されました H.C. Wainwright Buy
2015-01-23 繰り返されました ROTH Capital Buy
2014-07-08 再開されました Oppenheimer Perform
2014-02-11 開始されました Mizuho Buy
すべてを表示

Verastem Inc (VSTM) 最新ニュース

pulisher
Nov 20, 2024

KRAS Inhibitors Market Report 2034: Epidemiology Data, - openPR

Nov 20, 2024
pulisher
Nov 16, 2024

Data-Based Insights About Verastem Inc (VSTM) - Stocks Register

Nov 16, 2024
pulisher
Nov 15, 2024

OrbiMed Advisors LLC's Strategic Acquisition of Verastem Inc Sha - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

Alyeska Investment Group L.P.'s Strategic Acquisition of Veraste - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

Verastem, Inc. (NASDAQ:VSTM) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Nov 15, 2024
pulisher
Nov 15, 2024

Verastem, Inc. (NASDAQ:VSTM) Receives $14.57 Average PT from Analysts - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

Verastem's SWOT analysis: oncology firm's stock faces pivotal FDA decision - Investing.com India

Nov 14, 2024
pulisher
Nov 14, 2024

Verastem's SWOT analysis: oncology firm's stock faces pivotal FDA decision By Investing.com - Investing.com Canada

Nov 14, 2024
pulisher
Nov 13, 2024

Stonepine Capital Management, LLC Increases Stake in Verastem Inc - GuruFocus.com

Nov 13, 2024
pulisher
Nov 13, 2024

Such Is The Power Of Verastem Inc (NASDAQ: VSTM) - Stocks Register

Nov 13, 2024
pulisher
Nov 09, 2024

Verastem (NASDAQ:VSTM) Stock Rating Lowered by StockNews.com - Defense World

Nov 09, 2024
pulisher
Nov 07, 2024

Verastem CEO Paterson sells $3,118 in common stock - Investing.com

Nov 07, 2024
pulisher
Nov 07, 2024

Verastem CEO Paterson sells $3,118 in common stock By Investing.com - Investing.com UK

Nov 07, 2024
pulisher
Nov 07, 2024

Verastem Oncology Reports Third Quarter 2024 Financial Results and Highlights Recent Business Updates - BioSpace

Nov 07, 2024
pulisher
Nov 07, 2024

Verastem: Q3 Earnings Snapshot - The Washington Post

Nov 07, 2024
pulisher
Nov 06, 2024

Verastem, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 06, 2024
pulisher
Nov 04, 2024

Chugai PharmaceuticalVerastem Oncology's Announcement Regarding Avutometinib - Marketscreener.com

Nov 04, 2024
pulisher
Nov 02, 2024

Avutometinib With Defactinib for Recurrent KRAS Mutant LGSOC Completes Rolling New Drug Application - Pharmacy Times

Nov 02, 2024
pulisher
Nov 01, 2024

Verastem Oncology submits NDA for ovarian cancer treatment - Yahoo Finance

Nov 01, 2024
pulisher
Nov 01, 2024

Verastem (FRA:2VSA) Owner Earnings per Share (TTM) : -3.30 (As of Jun. 2024) - GuruFocus.com

Nov 01, 2024
pulisher
Oct 31, 2024

Verastem Oncology Completes Rolling NDA Submission to the FDA for Avutometinib Plus Defactinib as a Treatment for Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer - StockTitan

Oct 31, 2024
pulisher
Oct 31, 2024

Verastem Oncology to Participate in Upcoming Investor Conferences - BioSpace

Oct 31, 2024
pulisher
Oct 30, 2024

SG Americas Securities LLC Purchases New Position in Verastem, Inc. (NASDAQ:VSTM) - Defense World

Oct 30, 2024
pulisher
Oct 24, 2024

Verastem's SWOT analysis: ovarian cancer drug maker's stock faces pivotal year - Investing.com India

Oct 24, 2024
pulisher
Oct 21, 2024

Verastem, Inc. (NASDAQ:VSTM) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat

Oct 21, 2024
pulisher
Oct 18, 2024

Verastem preps an NDA as the stock struggles - BioWorld Online

Oct 18, 2024
pulisher
Oct 18, 2024

Verastem's (VSTM) "Buy" Rating Reiterated at HC Wainwright - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

Verastem Holders Endure Difficult Day, Analysts Holding Firm (VSTM) - AskTraders

Oct 18, 2024
pulisher
Oct 17, 2024

Truist keeps $15 target on Verastem amid sell-off By Investing.com - Investing.com UK

Oct 17, 2024
pulisher
Oct 17, 2024

Verastem Advances Cancer Treatment with Promising Trial Results - TipRanks

Oct 17, 2024
pulisher
Oct 17, 2024

Verastem Oncology Presents Positive Updated RAMP 201 Data for Avutometinib and Defactinib Combination in Recurrent Low-Grade Serous Ovarian Cancer at the International Gynecologic Cancer Society (IGCS) 2024 Annual Meeting - StockTitan

Oct 17, 2024
pulisher
Oct 15, 2024

This trade activity should not be overlooked: Verastem Inc (VSTM) - SETE News

Oct 15, 2024
pulisher
Oct 14, 2024

Verastem Inc (VSTM) stock: A year of ups and downs - US Post News

Oct 14, 2024
pulisher
Oct 10, 2024

Verastem CFO sells shares worth $17 to cover tax obligations By Investing.com - Investing.com Canada

Oct 10, 2024
pulisher
Oct 09, 2024

Verastem CFO sells shares worth $17 to cover tax obligations - Investing.com India

Oct 09, 2024
pulisher
Oct 09, 2024

Verastem Oncology Announces Details for the Oral Presentation of the Mature RAMP 201 Data Evaluating Avutometinib Plus Defactinib in Recurrent Low-Grade Serous Ovarian Cancer at the IGCS 2024 Annual Meeting - StockTitan

Oct 09, 2024
pulisher
Oct 07, 2024

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - StockTitan

Oct 07, 2024
pulisher
Oct 05, 2024

Verastem whipsaws after updates for cancer drug combo - MSN

Oct 05, 2024
pulisher
Oct 03, 2024

Taking the lead: Verastem Inc (VSTM) - SETE News

Oct 03, 2024
pulisher
Oct 02, 2024

Guggenheim’s latest rating for VSTM stock - Knox Daily

Oct 02, 2024
pulisher
Oct 02, 2024

Verastem Inc’s results are impressive - US Post News

Oct 02, 2024
pulisher
Oct 01, 2024

Nantahala Capital Management LLC Purchases Shares of 400,000 Verastem, Inc. (NASDAQ:VSTM) - Defense World

Oct 01, 2024
pulisher
Oct 01, 2024

Verastem Inc (VSTM) Stock: A Year of Decreases and Increases - The InvestChronicle

Oct 01, 2024
pulisher
Oct 01, 2024

Guggenheim Initiates Coverage of Verastem (VSTM) with Buy Recommendation - Nasdaq

Oct 01, 2024
pulisher
Oct 01, 2024

Nantahala Capital Management LLC Takes Position in Verastem, Inc. (NASDAQ:VSTM) - MarketBeat

Oct 01, 2024

Verastem Inc (VSTM) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
大文字化:     |  ボリューム (24 時間):